Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription 11.04.2022 6 Am Heart J 4 Am J Cardiol 2 Am J Emerg Med 2 Am J Med 3 Ann Thorac Surg 4 Arterioscler Thromb Vasc Biol 44 Catheter Cardiovasc Interv 1 Circ Cardiovasc Interv 1 Circ Cardiovasc Qual Outcomes 6 Circ J 1 Circ Res 1 Circulation 8 Eur Heart J 1 Hypertension 5 Int J Cardiol 6 J Am Coll Cardiol 6 J Cardiovasc Pharmacol 1 J Clin Endocrinol Metab 1 J Clin Epidemiol 1 J Mol Cell Cardiol 1 JAMA 1 Lancet 2 N Engl J Med 1 Psychosom Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. BAGIELLA E, Puskas JD, Moskowitz AJ, Gelijns AC, et al
   Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts.
   Am Heart J. 2022;246:12-20.
   PubMed         Abstract available
   
   
2. HARA H, Serruys PW, O'Leary N, Gao C, et al
   Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
   Am Heart J. 2022 Jan 3. pii: S0002-8703(21)00500.
   PubMed         Abstract available
   
   
3. BURSTEIN B, Anand V, Ternus B, Tabi M, et al
   Noninvasive Echocardiographic Cardiac Power Output Predicts Mortality in Cardiac Intensive Care Unit Patients.
   Am Heart J. 2021 Dec 22. pii: S0002-8703(21)00479.
   PubMed         Abstract available
   
   
4. NANNA MG, Vemulapalli S, Fordyce CB, Mark DB, et al
   The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial.
   Am Heart J. 2022;245:136-148.
   PubMed         Abstract available
   
   
5. HORNE BD, Muhlestein JB, Lappe DL, May HT, et al
   Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial.
   Am Heart J. 2022;244:125-134.
   PubMed         Abstract available
   
   
6. BAINEY KR, Fleg JL, Hochman JS, Kunichoff DF, et al
   Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia.
   Am Heart J. 2022;243:187-200.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

7. HACHIYA S, Kosuge H, Fujita Y, Hida S, et al
   Performance of Hybrid Imaging in the Diagnosis of Coronary Artery Disease.
   Am J Cardiol. 2022 Apr 1. pii: S0002-9149(22)00236.
   PubMed         Abstract available
   
   
8. KUMAR K, Chau T, Herman T, Samhan A, et al
   Transcatheter Aortic Valve Implantation in Patients With Previous Coronary Artery Bypass Grafting.
   Am J Cardiol. 2022 Apr 2. pii: S0002-9149(22)00258.
   PubMed        
   
   
9. CHEW NWS, Ng CH, Kong G, Lee KS, et al
   Meta-Analysis of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Narrowing.
   Am J Cardiol. 2022 Apr 4. pii: S0002-9149(22)00238.
   PubMed         Abstract available
   
   
10. LEVI N, Dadon Z, Steinmetz Y, Perel N, et al
    Prevalence, Predictors, and Outcomes of Patients With ST-Elevation Myocardial Infarction and Angiographically Significant Coronary Artery Disease of Non-Infarct-Related Artery.
    Am J Cardiol. 2022 Mar 31. pii: S0002-9149(22)00235.
    PubMed         Abstract available
    
    

    
    Am J Emerg Med

11. SUPPLES MW, Vaizer J, Liao M, Faris GW, et al
    Increased weight in patients with time-sensitive diagnosis is associated with longer prehospital on-scene times.
    Am J Emerg Med. 2022;53:236-239.
    PubMed         Abstract available
    
    
12. CHOI Y, Lee JH
    Dynamic changes in electrocardiographic findings between initial and follow-up electrocardiography: The role of the T/QRS ratio.
    Am J Emerg Med. 2022;54:8-14.
    PubMed         Abstract available
    
    

    
    Am J Med

13. WATANABE A
    Cardiorespiratory Fitness and Atherosclerotic Cardiovascular Outcomes: How Can We Apply the Look AHEAD Study to Daily Practice?
    Am J Med. 2022;135:e93.
    PubMed        
    
    
14. HIRSCH E, Qunaj L, Latib A, Galen B, et al
    Polycythemia Vera Presenting as ST-Segment Elevation Myocardial Infarction.
    Am J Med. 2022 Mar 31. pii: S0002-9343(22)00251.
    PubMed        
    
    

    
    Ann Thorac Surg

15. FATTOUCH K, Dioguardi P, Guccione F, Nogara A, et al
    10-Year Results of Mitral Repair and Coronary Bypass for Ischemic Regurgitation: A Randomized Trial.
    Ann Thorac Surg. 2022;113:816-822.
    PubMed         Abstract available
    
    
16. ARAI Y, Asai H, Ebuoka N, Oba J, et al
    Tubular pouch technique using aortic tissues for single coronary artery transfer.
    Ann Thorac Surg. 2022 Apr 1. pii: S0003-4975(22)00473.
    PubMed         Abstract available
    
    
17. SUN SB, Fan G, Farhaj Z, Hongxin L, et al
    A giant cardiac hemangioma encroaching the right coronary artery.
    Ann Thorac Surg. 2022 Mar 31. pii: S0003-4975(22)00470.
    PubMed         Abstract available
    
    

    
    Arterioscler Thromb Vasc Biol

18. GUPTA RM
    Causal Gene Confusion: The Complicated EDN1/PHACTR1 Locus for Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2022 Apr 7:101161ATVBAHA122317539.
    PubMed        
    
    
19. JARR KU, Kojima Y, Weissman IL, Leeper NJ, et al
    2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis.
    Arterioscler Thromb Vasc Biol. 2022 Apr 7:101161ATVBAHA122317049.
    PubMed         Abstract available
    
    
20. GAO JW, You S, Liu ZY, Hao QY, et al
    Different Metabolic Phenotypes of Obesity and Risk of Coronary Artery Calcium Progression and Incident Cardiovascular Disease Events: The CARDIA Study.
    Arterioscler Thromb Vasc Biol. 2022 Apr 7:ATVBAHA122317526.
    PubMed         Abstract available
    
    
21. TAM CF, Chan YH, Wong YK, Li Z, et al
    Multi-Omics Signatures Link to Ticagrelor Effects on Vascular Function in Patients With Acute Coronary Syndrome.
    Arterioscler Thromb Vasc Biol. 2022 Apr 7:101161ATVBAHA121317513.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

22. HERNANDEZ-SUAREZ DF, Azzalini L, Moroni F, Tinoco de Paula JE, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registry.
    Catheter Cardiovasc Interv. 2021 Dec 20. doi: 10.1002/ccd.30041.
    PubMed         Abstract available
    
    
23. GARBO R, Di Russo C, Sciahbasi A, Fedele S, et al
    The last resort during complex retrograde percutaneous coronary chronic total occlusion intervention: Extraplaque intracoronary lithotripsy to externally crush a heavy calcified occluded stent.
    Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30050.
    PubMed         Abstract available
    
    
24. LOW RJB, Khoo DZL, Ong PJL
    Case report: A novel application of the MicroVascular Plug (MVP) in treating distal coronary perforation.
    Catheter Cardiovasc Interv. 2022;99:502-507.
    PubMed         Abstract available
    
    
25. SHAMKHANI W, Kinnaird T, Ludman P, Rashid M, et al
    Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30081.
    PubMed         Abstract available
    
    
26. MARCHESE N, Barbato E, Di Gioia G, Stanislao M, et al
    Intracoronary pressures to predict myocardial viability in patients with ischemic left ventricular dysfunction.
    Catheter Cardiovasc Interv. 2022;99:271-279.
    PubMed         Abstract available
    
    
27. GOLDSTEIN JA, Mehta NK
    Extent of coronary atherosclerosis and ischemic myocardium foment sudden cardiac death.
    Catheter Cardiovasc Interv. 2022;99:812-813.
    PubMed        
    
    
28. TARANTINI G, Cardaioli F
    Coronary complete revascularization strategy: A puzzle still hard to complete.
    Catheter Cardiovasc Interv. 2022;99:639-640.
    PubMed        
    
    
29. ALASNAG M
    Sound and light editorial: The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2022;99:674-675.
    PubMed        
    
    
30. KHAN AA, Dangas G
    Is cardiac surgery backup required for left main stenting?
    Catheter Cardiovasc Interv. 2022;99:607-608.
    PubMed        
    
    
31. WIEBE J, Hofmann FJ, West N, Baumbach A, et al
    Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium.
    Catheter Cardiovasc Interv. 2022;99:533-540.
    PubMed         Abstract available
    
    
32. SHOAIB A, Spratt JC, Curzen N, Wilson S, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.
    Catheter Cardiovasc Interv. 2021 Nov 19. doi: 10.1002/ccd.30015.
    PubMed         Abstract available
    
    
33. AKL E, Pinilla-Echeverri N, Garcia-Garcia HM, Mehta SR, et al
    First in-human evaluation of a novel intravascular ultrasound and optical coherence tomography system for intracoronary imaging.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30001.
    PubMed         Abstract available
    
    
34. KANDZARI DE, Kirtane AJ, Mehran R, Price MJ, et al
    Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
    Catheter Cardiovasc Interv. 2022;99:583-592.
    PubMed         Abstract available
    
    
35. CUENIN L, Honton B, Aminfar F, Meyer P, et al
    Head to head comparison of quantitative flow ratio using 4-French and 6-French catheters versus fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;99:746-753.
    PubMed         Abstract available
    
    
36. KANDZARI DE, Alaswad K, Jaffer FA, Brilakis E, et al
    Safety and efficacy of dedicated guidewire, microcatheter, and guide catheter extension technologies for chronic total coronary occlusion revascularization: Primary results of the Teleflex Chronic Total Occlusion Study.
    Catheter Cardiovasc Interv. 2022;99:263-270.
    PubMed         Abstract available
    
    
37. CORTESE B, de la Torre Hernandez JM, Lanocha M, Ielasi A, et al
    Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2021 Sep 28. doi: 10.1002/ccd.29959.
    PubMed         Abstract available
    
    
38. FEENSTRA RGT, van Lavieren MA, Echavarria-Pinto M, Wijntjens GW, et al
    Respiration-related variations in Pd/Pa ratio and fractional flow reserve in resting conditions and during intravenous adenosine administration.
    Catheter Cardiovasc Interv. 2022;99:844-852.
    PubMed         Abstract available
    
    
39. LATIF A, Ahsan MJ, Lateef N, Aurit S, et al
    Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30017.
    PubMed         Abstract available
    
    
40. LEE K, Lee PH, Lee SW, Kwon O, et al
    Primary versus rescue retrograde approach for chronic total coronary occlusion.
    Catheter Cardiovasc Interv. 2022;99:219-225.
    PubMed         Abstract available
    
    
41. XU R, Shi Y, Chang S, Qin Q, et al
    Outcomes of contemporary versus conventional reverse controlled and antegrade and retrograde subintimal tracking in chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2022;99:226-233.
    PubMed         Abstract available
    
    
42. KUFNER S, Rai H, Wiebe J, Altevogt F, et al
    A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (I
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30014.
    PubMed         Abstract available
    
    
43. NOGIC J, Nerlekar N, Soon K, Freeman M, et al
    Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry.
    Catheter Cardiovasc Interv. 2022;99:554-562.
    PubMed         Abstract available
    
    
44. BISWAS S, Dinh D, Duffy SJ, Brennan A, et al
    Characteristics and outcomes of unsuccessful percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29886.
    PubMed         Abstract available
    
    
45. EBERLI FR, Stoll HP, Urban P, Morice MC, et al
    Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III study.
    Catheter Cardiovasc Interv. 2022;99:593-600.
    PubMed         Abstract available
    
    
46. VAN HEMERT ND, Rozemeijer R, Voskuil M, Stein M, et al
    Clinical outcomes after permanent polymer or polymer-free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy.
    Catheter Cardiovasc Interv. 2022;99:366-372.
    PubMed         Abstract available
    
    
47. NAKAMURA S, Yonetsu T, Hoshino M, Hada M, et al
    Anatomical-functional discordance between quantitative coronary angiography and diastolic pressure ratio during wave-free period.
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29680.
    PubMed         Abstract available
    
    
48. IQBAL MB, Moore PT, Nadra IJ, Robinson SD, et al
    Complete revascularization in stable multivessel coronary artery disease: A real world analysis from the British Columbia Cardiac Registry.
    Catheter Cardiovasc Interv. 2022;99:627-638.
    PubMed         Abstract available
    
    
49. GONG Y, Zheng B, Yi T, Yang F, et al
    Coronary angiography-derived contrast fractional flow reserve.
    Catheter Cardiovasc Interv. 2021 Feb 15. doi: 10.1002/ccd.29558.
    PubMed         Abstract available
    
    
50. ALAOUR B, Onwordi E, Khan A, Menexi C, et al
    Outcome of left main stem percutaneous coronary intervention in a UK nonsurgical center: A 5-year clinical experience.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29530.
    PubMed         Abstract available
    
    
51. G TOTH G, Ono M, Buschmann E, Wu X, et al
    Usability of Fantom Encore(R) scaffold in non-complex bifurcations-Analysis in bench models.
    Catheter Cardiovasc Interv. 2022;99:424-432.
    PubMed         Abstract available
    
    
52. SAITO Y, Wijns W, Baumbach A, Xu B, et al
    Differential impact of abluminal groove-filled biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent on and off dual antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;99:357-365.
    PubMed         Abstract available
    
    
53. HIRAI T, Grantham JA, Sapontis J, Nicholson WJ, et al
    Development and validation of a prediction model for angiographic perforation during chronic total occlusion percutaneous coronary intervention: OPEN-CLEAN perforation score.
    Catheter Cardiovasc Interv. 2021 Jan 13. doi: 10.1002/ccd.29466.
    PubMed         Abstract available
    
    
54. HIDALGO F, Gonzalez-Manzanares R, Ojeda S, Benito-Gonzalez T, et al
    Instantaneous wave-free ratio for guiding treatment of nonculprit lesions in patients with acute coronary syndrome: A retrospective study.
    Catheter Cardiovasc Interv. 2022;99:489-496.
    PubMed         Abstract available
    
    
55. OSMAN M, Ghaffar YA, Osman K, Kheiri B, et al
    Gender-based outcomes of coronary bifurcation stenting: A report from the National Readmission Database.
    Catheter Cardiovasc Interv. 2022;99:433-439.
    PubMed         Abstract available
    
    
56. JENTZER JC, van Diepen S, Henry TD, Baran DA, et al
    Influence of intra-aortic balloon pump on mortality as a function of cardiogenic shock severity.
    Catheter Cardiovasc Interv. 2021 May 28. doi: 10.1002/ccd.29800.
    PubMed         Abstract available
    
    
57. ERDOGAN E, Huang X, Cooper J, Jain A, et al
    End-diastolic segmentation of intravascular ultrasound images enables more reproducible volumetric analysis of atheroma burden.
    Catheter Cardiovasc Interv. 2021 Aug 17. doi: 10.1002/ccd.29917.
    PubMed         Abstract available
    
    
58. KOSMOPOULOS M, Bartos JA, Raveendran G, Goslar T, et al
    Coronary artery disease burden relation with the presentation of acute cardiac events and ventricular fibrillation.
    Catheter Cardiovasc Interv. 2022;99:804-811.
    PubMed         Abstract available
    
    
59. HUSSAIN Y, Gaston S, Kluger J, Shah T, et al
    Long term outcomes of ultrathin versus standard thickness second-generation drug eluting stents: Meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2022;99:563-574.
    PubMed         Abstract available
    
    
60. G TOTH G, Collet C, Langhoff Thuesen A, Mizukami T, et al
    Influence of fractional flow reserve on grafts patency: Systematic review and patient-level meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:730-735.
    PubMed         Abstract available
    
    
61. MCINERNEY A, Travieso Gonzalez A, Castro Mejia A, Tirado-Conte G, et al
    Long-term outcomes after deferral of revascularization of in-stent restenosis using fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;99:723-729.
    PubMed         Abstract available
    
    
62. HARDING SA, Webber B, Fairley S, Ormiston JA, et al
    Real-time intravascular ultrasound guidance: A novel technique for accurate placement of ostial stents.
    Catheter Cardiovasc Interv. 2022;99:699-705.
    PubMed         Abstract available
    
    
63. HAKEEM A, Hou L, Shah K, Agarwal SK, et al
    Derivation and validation of Pd/Pa in the assessment of residual ischemia post-intervention: A prospective all-comer registry.
    Catheter Cardiovasc Interv. 2022;99:714-722.
    PubMed         Abstract available
    
    
64. KAUL U, Abhyankar A, K Abhaichand R, Bhagwat A, et al
    Serial evaluation of vascular responses after implantation of everolimus-eluting coronary stent by optical coherence tomography.
    Catheter Cardiovasc Interv. 2021 Jun 1. doi: 10.1002/ccd.29794.
    PubMed         Abstract available
    
    
65. SCARSINI R, Terentes-Printzios D, Shanmuganathan M, Kotronias RA, et al
    Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI.
    Catheter Cardiovasc Interv. 2022;99:329-339.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

66. XU J, Lo S, Mussap CJ, French JK, et al
    Impact of Ticagrelor Versus Clopidogrel on Coronary Microvascular Function After Non-ST-Segment-Elevation Acute Coronary Syndrome.
    Circ Cardiovasc Interv. 2022 Apr 4:101161CIRCINTERVENTIONS121011419.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Qual Outcomes

67. LOWENSTERN A, Alexander KP, Pagidipati NJ, Hill CL, et al
    Presenting Symptoms in Patients Undergoing Coronary Artery Disease Evaluation: Association With Noninvasive Test Results and Clinical Outcomes in the PROMISE Trial.
    Circ Cardiovasc Qual Outcomes. 2022 Apr 4:101161CIRCOUTCOMES121008298.
    PubMed         Abstract available
    
    

    
    Circ J

68. YOSHIOKA G, Sonoda S, Aishima S, Node K, et al
    Multimodality Imaging Approach for a Left Ventricular Aneurysm in a Patient With Myocardial Infarction and Non-Obstructive Coronary Arteries.
    Circ J. 2022 Apr 5. doi: 10.1253/circj.CJ-21-1080.
    PubMed        
    
    
69. SAWANO M, Kohsaka S, Ishii H, Numasawa Y, et al
    One-Year Outcome After Percutaneous Coronary Intervention for Acute Coronary Syndrome- An Analysis of 20,042 Patients From a Japanese Nationwide Registry.
    Circ J. 2021;85:1756-1767.
    PubMed         Abstract available
    
    
70. VAN ZANDVOORT LJC, Otsuka K, Villiger M, Neleman T, et al
    Polarimetric Signatures of Coronary Thrombus in Patients With Acute Coronary Syndrome.
    Circ J. 2021;85:1806-1813.
    PubMed         Abstract available
    
    
71. INAGAKI Y, Arashi H, Yamaguchi J, Ogawa H, et al
    Greater Change in the Eicosapentaenoic Acid to Arachidonic Acid Ratio Is Associated With Decreased Incidence of Cardiovascular Events in Acute Coronary Syndrome Patients With Elevated Triglyceride Levels.
    Circ J. 2021;85:1746-1753.
    PubMed         Abstract available
    
    
72. SHIBATA N, Umemoto N, Tanaka A, Takagi K, et al
    Clinical Outcomes Following Emergent Percutaneous Coronary Intervention for Acute Total/Subtotal Occlusion of the Left Main Coronary Artery.
    Circ J. 2021;85:1789-1796.
    PubMed         Abstract available
    
    
73. KHALIFA AKM, Kubo T, Shimamura K, Ino Y, et al
    Impact of Optical Coherence Tomography Imaging on Decision-Making During Percutaneous Coronary Intervention in Patients Presented With Acute Coronary Syndromes.
    Circ J. 2021;85:1781-1788.
    PubMed         Abstract available
    
    

    
    Circ Res

74. YOUNG A, Bradley LA, Farrar E, Bilcheck HO, et al
    Inhibition of DYRK 1a Enhances Cardiomyocyte Cycling After Myocardial Infarction.
    Circ Res. 2022 Apr 4:101161CIRCRESAHA121320005.
    PubMed         Abstract available
    
    

    
    Circulation

75. SINGH T, Khan H, Gamble DT, Scally C, et al
    Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications.
    Circulation. 2022;145:1002-1019.
    PubMed         Abstract available
    
    

    
    Eur Heart J

76. ROMAGUERA R, Salinas P, Gomez-Lara J, Brugaletta S, et al
    Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.
    Eur Heart J. 2022;43:1320-1330.
    PubMed         Abstract available
    
    
77. DAVIERWALA PM, Gao C, Thuijs DJFM, Wang R, et al
    Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.
    Eur Heart J. 2021 Aug 18. pii: 6354120. doi: 10.1093.
    PubMed         Abstract available
    
    
78. BUCCIARELLI-DUCCI C, Ajmone-Marsan N, Di Carli M, Nicol E, et al
    The year in cardiovascular medicine 2021: imaging.
    Eur Heart J. 2022;43:1288-1295.
    PubMed         Abstract available
    
    
79. BYRNE RA, Rai H, Colleran R
    Amphilimus-eluting stents in coronary artery disease: finally, a sweet spot for patients with diabetes mellitus?
    Eur Heart J. 2022;43:1331-1333.
    PubMed        
    
    
80. BANNING AP, Serruys P, De Maria GL, Ryan N, et al
    Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
    Eur Heart J. 2021 Oct 7. pii: 6383065. doi: 10.1093.
    PubMed         Abstract available
    
    
81. HAN Y
    Chinese expert consensus statement on dual antiplatelet therapy in patients with coronary artery disease.
    Eur Heart J. 2022;43:1283-1285.
    PubMed        
    
    
82. CHIKWE J, Alfieri OR
    The optimal strategy for multivessel coronary revascularization.
    Eur Heart J. 2021 Nov 11. pii: 6425621. doi: 10.1093.
    PubMed        
    
    
83. SAMMONS E, Hopewell JC, Chen F, Stevens W, et al
    Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
    Eur Heart J. 2022;43:1416-1424.
    PubMed         Abstract available
    
    

    
    Hypertension

84. PARCHA V, Pampana A, Bress AP, Irvin MR, et al
    Association of Polygenic Risk Score With Blood Pressure and Adverse Cardiovascular Outcomes in Individuals With Type II Diabetes: Insights From the ACCORD Trial.
    Hypertension. 2022 Apr 4:HYPERTENSIONAHA12218976.
    PubMed        
    
    

    
    Int J Cardiol

85. LI Q, Li Z, Li T, Liu C, et al
    Involvement of the crosstalk between Nrf2 and NF-kappaB pathways regulated by SIRT1 in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2022;355:44.
    PubMed        
    
    
86. TSUGU T, Tanaka K, Belsack D, Devos H, et al
    Effects of left ventricular mass on computed tomography derived fractional flow reserve in significant obstructive coronary artery disease.
    Int J Cardiol. 2022;355:59-64.
    PubMed         Abstract available
    
    
87. HOLZKNECHT M, Reinstadler SJ
    CRP: a potential target in reperfused STEMI? Reply to the letter: "Targeting CRP in microvascular obstruction after PCI".
    Int J Cardiol. 2022;355:5.
    PubMed        
    
    
88. DIEU X, Chabrun F, Prunier F, Angoulvant D, et al
    Post-infarct cardiac remodeling predictions with machine learning.
    Int J Cardiol. 2022;355:1-4.
    PubMed         Abstract available
    
    
89. BOTTO GL, Mantovani LG, Cortesi PA, De Ponti R, et al
    The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00483.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

90. MENSAH GA, Fuster V
    Sex and Gender Differences in Cardiovascular Health.
    J Am Coll Cardiol. 2022;79:1385-1387.
    PubMed        
    
    
91. CLAYTON JA, Gaugh MD
    Sex as a Biological Variable in Cardiovascular Diseases: JACC Focus Seminar 1/7.
    J Am Coll Cardiol. 2022;79:1388-1397.
    PubMed         Abstract available
    
    
92. GAUDINO M, Di Franco A, Cao D, Giustino G, et al
    Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7.
    J Am Coll Cardiol. 2022;79:1407-1425.
    PubMed         Abstract available
    
    
93. GRANDIN EW, Nunez JI, Willar B, Kennedy K, et al
    Mechanical Left Ventricular Unloading in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation.
    J Am Coll Cardiol. 2022;79:1239-1250.
    PubMed         Abstract available
    
    
94. MEHRAN R, Cao D, Vogel B
    Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG.
    J Am Coll Cardiol. 2022;79:1285-1287.
    PubMed        
    
    
95. SOLOLA NUSSBAUM S, Henry S, Yong CM, Daugherty SL, et al
    Sex-Specific Considerations in the Presentation, Diagnosis, and Management of Ischemic Heart Disease: JACC Focus Seminar 2/7.
    J Am Coll Cardiol. 2022;79:1398-1406.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

96. AKYILDIZ AG, Biondi-Zoccai G, De Biase D
    Impact of the Gastrointestinal Tract Microbiota on Cardiovascular Health and Pathophysiology.
    J Cardiovasc Pharmacol. 2022 Apr 6. pii: 00005344-990000000-00021.
    PubMed         Abstract available
    
    
97. DAI H, Zhao N, Zheng Y
    CircLDLR modulates the proliferation and apoptosis of vascular smooth muscle cells in coronary artery disease through miR-26-5p/KDM6A axis.
    J Cardiovasc Pharmacol. 2022 Apr 6. pii: 00005344-990000000-00018.
    PubMed         Abstract available
    
    
98. ADEVA-ANDANY MM, Fernandez-Fernandez C, Carneiro-Freire N, Castro-Quintela E, et al
    Cardiovascular protection associated with cilostazol, colchicine and target of rapamycin inhibitors.
    J Cardiovasc Pharmacol. 2022 Apr 6. pii: 00005344-990000000-00019.
    PubMed         Abstract available
    
    
99. LIU X, Qi K, Gong Y, Long X, et al
    Ferulic Acid Alleviates Myocardial Ischemia Reperfusion Injury Via Upregulating AMPKalpha2 Expression-Mediated Ferroptosis Depression.
    J Cardiovasc Pharmacol. 2021;79:489-500.
    PubMed         Abstract available
    
    
100. DENG X, Liu Y, Xu Z, Wang Z, et al
     lncRNA Nuclear Factor of Activated T Cells Knockdown Alleviates Hypoxia/Reoxygenation-induced Cardiomyocyte Apoptosis by Upregulating HIF-1alpha Expression.
     J Cardiovasc Pharmacol. 2022;79:479-488.
     PubMed         Abstract available
     
     
101. VLACHAKIS PK, Varlamos C, Benetou DR, Kanakakis I, et al
     Periprocedural Antithrombotic Treatment in Complex Percutaneous Coronary Intervention.
     J Cardiovasc Pharmacol. 2022;79:407-419.
     PubMed         Abstract available
     
     

     
     J Clin Endocrinol Metab

102. DENG X, Zhang C, Wang P, Wei W, et al
     Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes.
     J Clin Endocrinol Metab. 2022 Apr 9. pii: 6565990. doi: 10.1210.
     PubMed         Abstract available
     
     

     
     J Clin Epidemiol

103. TERVONEN T, Prawitz T, Chua GN, Hyacinthe J, et al
     Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment.
     J Clin Epidemiol. 2022;144:84-92.
     PubMed         Abstract available
     
     

     
     J Mol Cell Cardiol

104. KONG D, Yu Y
     Prostaglandin D2 signaling and cardiovascular homeostasis.
     J Mol Cell Cardiol. 2022;167:97-105.
     PubMed         Abstract available
     
     

     
     JAMA

105. RABER L, Ueki Y, Otsuka T, Losdat S, et al
     Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
     JAMA. 2022 Apr 3. pii: 2790913. doi: 10.1001/jama.2022.5218.
     PubMed         Abstract available
     
     

     
     Lancet

106. BERGMARK BA, Mathenge N, Merlini PA, Lawrence-Wright MB, et al
     Acute coronary syndromes.
     Lancet. 2022;399:1347-1358.
     PubMed         Abstract available
     
     

     
     N Engl J Med

107. INGELFINGER JR
     Childhood Risk Factors and Prediction of Adult Cardiovascular End Points.
     N Engl J Med. 2022 Apr 4. doi: 10.1056/NEJMe2203743.
     PubMed        
     
     
108. JACOBS DR JR, Woo JG, Sinaiko AR, Daniels SR, et al
     Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events.
     N Engl J Med. 2022 Apr 4. doi: 10.1056/NEJMoa2109191.
     PubMed         Abstract available
     
     

     
     Psychosom Med

109. DASA O, Mahmoud AN, Kaufmann PG, Ketterer M, et al
     Relationship of Psychological Characteristics to Daily Life Ischemia: An Analysis From the National Heart, Lung, and Blood Institute Psychophysiological Investigations in Myocardial Ischemia.
     Psychosom Med. 2022;84:359-367.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: